Mature neurons from iPSCs unveil neurodegeneration-related pathways in mucopolysaccharidosis type II: GSK-3β inhibition for therapeutic potential

Abstract Mucopolysaccharidosis (MPS) type II is caused by a deficiency of iduronate-2-sulfatase and is characterized by the accumulation of glycosaminoglycans (GAGs). Without effective therapy, the severe form of MPS II causes progressive neurodegeneration and death. This study generated multiple cl...

Full description

Bibliographic Details
Published in:	Cell Death and Disease
Main Authors:	Tzu-Yu Chen, Shuan-Pei Lin, De-Fong Huang, Hsien-Sung Huang, Feng-Chiao Tsai, Li-Jen Lee, Hsiang-Yu Lin, Hsiang-Po Huang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-04-01
Online Access:	https://doi.org/10.1038/s41419-024-06692-9

Similar Items

Transcriptome-wide RNA 5-methylcytosine profiles of human iPSCs and iPSC-derived cardiomyocytes
by: Szu-Ying Chen, et al.
Published: (2024-12-01)

iPSCs are safe!
by: Hualong Yan, et al.
Published: (2017-05-01)

n-Butylidenephthalide recovered calcium homeostasis to ameliorate neurodegeneration of motor neurons derived from amyotrophic lateral sclerosis iPSCs.
by: Yu-Chen Deng, et al.
Published: (2024-01-01)

n-Butylidenephthalide recovered calcium homeostasis to ameliorate neurodegeneration of motor neurons derived from amyotrophic lateral sclerosis iPSCs
by: Yu-Chen Deng, et al.
Published: (2024-01-01)

Awareness of Mucopolysaccharidosis in an Otorhinolaryngologic Clinic
by: Hsiang-Yu Lin
Published: (2017-04-01)

Modeling cartilage pathology in mucopolysaccharidosis VI using iPSCs reveals early dysregulation of chondrogenic and metabolic gene expression
by: M. Broeders, et al.
Published: (2022-12-01)

The Application of iPSCs in Tumour Immunotherapy
by: Peinan Chen, et al.
Published: (2025-01-01)

Mucopolysaccharidosis Type II—An Unexpected “3 in 1” Family
by: Hsiang-Yu Lin
Published: (2016-08-01)

iPSCs in Modeling and Therapy of Osteoarthritis
by: Maria Csobonyeiova, et al.
Published: (2021-02-01)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-07-01)

Applications of iPSCs in Cancer Research
by: Jean J. Kim
Published: (2015-01-01)

Neurodegeneration and aging pathways in Mucopolysaccharidosis IIIB
by: Yorran Hardman Araújo Montenegro
Published: (2025-07-01)

Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria
by: Xiao-Yu Cheng, et al.
Published: (2020-04-01)

Effect of Mutated <i>ids</i> Overexpression on IDS Enzyme Activity and Developmental Phenotypes in Zebrafish Embryos: A Valuable Index for Assessing Critical Point-Mutations Associated with Mucopolysaccharidosis Type II Occurrence in Humans
by: Cheng-Yung Lin, et al.
Published: (2020-10-01)

iPSCs and iPSC-derived cells as a model of human genetic and epigenetic variation
by: Kara Quaid, et al.
Published: (2025-02-01)

iPSCs: From Bench to Clinical Bed
by: Yujing Li, et al.
Published: (2016-01-01)

Differentiation of human iPSCs into functional podocytes.
by: Caroline Rauch, et al.
Published: (2018-01-01)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
by: Hsiang-Yu Lin, et al.
Published: (2018-08-01)

Hypoimmunogenic Human iPSCs for Repair and Regeneration in the CNS
by: Haiwei Zhang, et al.
Published: (2025-08-01)

Nanog-Independent Reprogramming to iPSCs with Canonical Factors
by: Ava C. Carter, et al.
Published: (2014-02-01)

Modeling leukemia with pediatric acute leukemia patient-derived iPSCs
by: Ting Li, et al.
Published: (2021-07-01)

Advancements in Otorhinolaryngological Management of Mucopolysaccharidosis: A Comprehensive Review
by: Chung-Lin Lee, et al.
Published: (2024-07-01)

Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
by: Nikita Arnst, et al.
Published: (2021-07-01)

Systematic Analysis of Multiple Imaging Modalities in Infants Diagnosed with Mucopolysaccharidosis by Newborn Screening
by: Chung-Lin Lee, et al.
Published: (2025-04-01)

Generation of phenotypically stable and functionally mature human bone marrow MSCs derived Schwann cells via the induction of human iPSCs-derived sensory neurons
by: Yu Pan, et al.
Published: (2025-03-01)

Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells
by: Pooja Hor, et al.
Published: (2020-09-01)

Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis
by: Akshay Bhinge, et al.
Published: (2017-04-01)

Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity
by: Kenji Kubara, et al.
Published: (2018-08-01)

Differentiation of Human Induced Pluripotent Stem Cells (iPSCs) into an Effective Model of Forebrain Neural Progenitor Cells and Mature Neurons
by: Scott Bell, et al.
Published: (2019-03-01)

Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs
by: Yi Yang, et al.
Published: (2018-01-01)

Osteochondral Tissue Chip Derived From iPSCs: Modeling OA Pathologies and Testing Drugs
by: Zixuan Lin, et al.
Published: (2019-12-01)

Naive-like ESRRB+ iPSCs with the Capacity for Rapid Neural Differentiation
by: Fumihiko Kisa, et al.
Published: (2017-12-01)

Generation of Scaffoldless Hyaline Cartilaginous Tissue from Human iPSCs
by: Akihiro Yamashita, et al.
Published: (2015-03-01)

The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside
by: Nina Xie, et al.
Published: (2016-01-01)

Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids
by: Ekaterina Pecksen, et al.
Published: (2024-05-01)

Advances and challenges in modeling inherited peripheral neuropathies using iPSCs
by: Jonas Van Lent, et al.
Published: (2024-06-01)

Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases
by: Dong-Hun Lee, et al.
Published: (2024-06-01)

Human iPSCs as Model Systems for BMP-Related Rare Diseases
by: Gonzalo Sánchez-Duffhues, et al.
Published: (2023-09-01)

Modelling Takenouchi-Kosaki syndrome using disease-specific iPSCs
by: Suganya Thanasegaran, et al.
Published: (2023-12-01)

Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs
by: Lina Fu, et al.
Published: (2016-02-01)